Skip to main content
Figure 6 | BMC Molecular Biology

Figure 6

From: Down-regulation of human topoisomerase IIα expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions

Figure 6

Endogenous topoisomerase IIα decreases concomitantly with decreased Sp1 and increased Sp3 after treatment with doxorubicin. (A) Topoisomerase IIα; (B) Sp1; (C) Sp3; (D) tubulin control, at time points 0 hours (i), 2 hours (ii), and 24 hours (iii) after exposure to doxorubicin in MDA MB 231 cells. The three proteins bracketed in C represent the isoforms of Sp3 produced from alternative start codons. Results show the average of three experiments carried out in triplicate and are expressed as ± SEM where n = 9, *** p < 0.001, ** p < 0.01, and * p < 0.05. The insert shows one indicative immunoblot.

Back to article page